AbtBioConsult ApS: Financial statements 2022
CVR: 42368660
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
AbtBioConsult ApS (CVR 42368660) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,939,417 and a net result of DKK -433,815 compared with DKK -574,862 the year before. That is a decrease of 22.8% compared with the year before. Equity in the 2022 report amounted to DKK 4,871,763. The solvency ratio was 90.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,939,417
- Profit/Loss
- DKK -433,815
- Equity
- DKK 4,871,763
- Total Assets
- DKK 5,358,163
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.9 mio. | -434 t. | 4.9 mio. | 1 |
| 2021 | - | 2.5 mio. | -575 t. | 5.3 mio. | 1 |
Official annual report
Keep an eye on AbtBioConsult ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
AbtBioConsult ApS has published its annual report for 2021. Gross profit came to DKK 2,513,092, and the net result was DKK -574,862.
About AbtBioConsult ApS
AbtBioConsult ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anne Bondgaard Tolstrup. The company is owned by Anne Bondgaard Tolstrup. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,937,411 and a net result of DKK 692,691 compared with DKK 485,221 the year before. Equity in the 2025 report amounted to DKK 4,523,051.